Lundbeck plotting up to 160 R&D job cuts as it rebuilds pipeline

Lundbeck wants to rebuild its pipeline and sharpen focus on neuroscience in the coming years, and this will mean swinging the ax across its research organization.

As it plans to “refocus and reinvigorate research and development,” the Danish biotech said it would have to cull 130 to 160 R&D staffers, with around 100 coming from its R&D site in Denmark and the rest likely from its other R&D site in the U.S.